QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

NCT06551116 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Metastatic Breast Cancer

Interventions

DIAGNOSTIC_TEST: CE-10-IVD

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]
[object Object]